Djalila Mekahli

Djalila Mekahli

Auto-generated profile, based on publicly available information

Djalila Mekahli

PKD Research Group, Laboratory of Ion Channel Research, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2018 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
KDKristien Daenen
Kristien Daenen
AAAsmin Andries
Asmin Andries
DMDjalila Mekahli
Djalila Mekahli
ASAnn Van Schepdael
Ann Van Schepdael
FJFrançois Jouret
François Jouret
BBBert Bammens
Bert Bammens

9 March 2011 in Cold Spring Harbor Perspectives in Biology
Verified
Journal Article
Closed access
PDF file
DMDjalila Mekahli
Djalila Mekahli
GBGeert Bultynck
Geert Bultynck
Jan ParysJan Parys
Jan Parys
HSHumbert De Smedt
Humbert De Smedt
LMLudwig Missiaen
Ludwig Missiaen
The endoplasmic reticulum (ER) as an intracellular Ca2+ store not only sets up cytosolic Ca2+ signals, but, among other functions, also assembles and folds newly synthesized proteins. Alterations in ER homeostasis, including severe Ca2+ depletion, are an upstream event in the pathophysiology of many diseases. On the one hand, insufficient release of activator Ca2+ may no longer sustain essential cell functions. On the other hand, loss of luminal Ca2+ causes ER stress and activates an unfolded protein response, which, depending on the duration and severity of the stress, can reestablish normal ER function or lead to cell death. We will review these various diseases by mainly focusing on the mechanisms that cause ER Ca2+ depletion.

1 August 2009 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
DMDjalila Mekahli
Djalila Mekahli
ALAurelia Liutkus
Aurelia Liutkus
BRBruno Ranchin
Bruno Ranchin
AYAnchalee Yu
Anchalee Yu
LBLucie Bessenay
Lucie Bessenay
PCPierre Cochat
Pierre Cochat

22 May 2019 in Nature Reviews Nephrology
Verified
Journal Article
Open access
PDF file
CGCharlotte Gimpel
Charlotte Gimpel
CBCarsten Bergmann
Carsten Bergmann
DBDetlef Bockenhauer
Detlef Bockenhauer
LBLuc Breysem
Luc Breysem
MCMelissa A. Cadnapaphornchai
Melissa A. Cadnapaphornchai
FSFranz Schaefer
Franz Schaefer
These recommendations were systematically developed on behalf of the Network for Early Onset Cystic Kidney Disease (NEOCYST) by an international group of experts in autosomal dominant polycystic kidney disease (ADPKD) from paediatric and adult nephrology, human genetics, paediatric radiology and ethics specialties together with patient representatives. They have been endorsed by the International Pediatric Nephrology Association (IPNA) and the European Society of Paediatric Nephrology (ESPN). For asymptomatic minors at risk of ADPKD, ongoing surveillance (repeated screening for treatable disease manifestations without diagnostic testing) or immediate diagnostic screening are equally valid clinical approaches. Ultrasonography is the current radiological method of choice for screening. Sonographic detection of one or more cysts in an at-risk child is highly suggestive of ADPKD, but a negative scan cannot rule out ADPKD in childhood. Genetic testing is recommended for infants with very-early-onset symptomatic disease and for children with a negative family history and progressive disease. Children with a positive family history and either confirmed or unknown disease status should be monitored for hypertension (preferably by ambulatory blood pressure monitoring) and albuminuria. Currently, vasopressin antagonists should not be offered routinely but off-label use can be considered in selected children. No consensus was reached on the use of statins, but mTOR inhibitors and somatostatin analogues are not recommended. Children with ADPKD should be strongly encouraged to achieve the low dietary salt intake that is recommended for all children.

1 June 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
ESEva Sammels
Eva Sammels
BDBenoit Devogelaere
Benoit Devogelaere
DMDjalila Mekahli
Djalila Mekahli
GBGeert Bultynck
Geert Bultynck
LMLudwig Missiaen
Ludwig Missiaen
HSHumbert De Smedt
Humbert De Smedt
Autosomal dominant polycystic kidney disease is characterized by the loss-of-function of a signaling complex involving polycystin-1 and polycystin-2 (TRPP2, an ion channel of the TRP superfamily), resulting in a disturbance in intracellular Ca(2+) signaling. Here, we identified the molecular determinants of the interaction between TRPP2 and the inositol 1,4,5-trisphosphate receptor (IP(3)R), an intracellular Ca(2+) channel in the endoplasmic reticulum. Glutathione S-transferase pulldown experiments combined with mutational analysis led to the identification of an acidic cluster in the C-terminal cytoplasmic tail of TRPP2 and a cluster of positively charged residues in the N-terminal ligand-binding domain of the IP(3)R as directly responsible for the interaction. To investigate the functional relevance of TRPP2 in the endoplasmic reticulum, we re-introduced the protein in TRPP2(-/-) mouse renal epithelial cells using an adenoviral expression system. The presence of TRPP2 resulted in an increased agonist-induced intracellular Ca(2+) release in intact cells and IP(3)-induced Ca(2+) release in permeabilized cells. Using pathological mutants of TRPP2, R740X and D509V, and competing peptides, we demonstrated that TRPP2 amplified the Ca(2+) signal by a local Ca(2+)-induced Ca(2+)-release mechanism, which only occurred in the presence of the TRPP2-IP(3)R interaction, and not via altered IP(3)R channel activity. Moreover, our results indicate that this interaction was instrumental in the formation of Ca(2+) microdomains necessary for initiating Ca(2+)-induced Ca(2+) release. The data strongly suggest that defects in this mechanism may account for the altered Ca(2+) signaling associated with pathological TRPP2 mutations and therefore contribute to the development of autosomal dominant polycystic kidney disease.

1 March 2019 in Radiology
Verified
Journal Article
Open access
CGCharlotte Gimpel
Charlotte Gimpel
EAE. Fred Avni
E. Fred Avni
LBLuc Breysem
Luc Breysem
KBKathrin Burgmaier
Kathrin Burgmaier
ACAnna Caroli
Anna Caroli
FSFranz Schaefer
Franz Schaefer
This international consensus statement on imaging of cystic kidney diseases in children highlights US as the most useful imaging modality with which to diagnose a wide variety of underlying disorders and for clinical follow-up. Kidney cysts can manifest as focal disease (simple and complex kidney cysts), affect a whole kidney (eg, multicystic dysplastic kidney or cystic dysplasia), or manifest as bilateral cystic disease (eg, autosomal recessive polycystic kidney disease [ARPKD] or autosomal dominant polycystic kidney disease [ADPKD]). In children, as opposed to adults, a larger proportion of kidney cysts are due to genetic diseases (eg, HNF1B nephropathy, various ciliopathies, and tuberous sclerosis complex), and fewer patients have simple cysts or acquired cystic kidney disease. The purpose of this consensus statement is to provide clinical guidance on standardization of imaging tests to evaluate kidney cysts in children. A committee of international experts in pediatric nephrology, pediatric radiology, pediatric US, and adult nephrology prepared systematic literature reviews and formulated recommendations at a consensus meeting. The final statement was endorsed by the European Society of Pediatric Radiology, the European Fede...